FBP1 and renal carcinoma: FBP1 is known to negatively regulate glycolysis in various cancers [15, 16, 24], and it can suppress glycolysis and cell proliferation by interacting with the hypoxia-inducible factor inhibitory domain of renal carcinoma [25].